The current chemotherapy for advanced pancreatic cancer including the result of phase II study of irinotecan (CPT-11)

被引：0
|
作者：
Sumii, Toshihiko [1 ]
Fujimori, Nao [1 ]
Funakoshi, Akihiro [1 ]
机构：
[1] Kyushu Natl Canc Ctr, Dept Gastroenterol, Fukuoka, Japan
来源：
PANCREAS | 2008年 / 37卷 / 01期
关键词：
D O I：
10.1097/01.mpa.0000325612.89290.b5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant radiochemotherapy with irinotecan (CPT-11) and capecitabine in locally advanced rectal cancer
    Kraus-Tiefenbacher, U
    Hofheinz, R
    von Gerstenberg-Heffdorf, B
    Willeke, F
    Hochhaus, A
    Wenz, F
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 31 - 31
  • [32] A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer
    Manabu Shiozawa
    Nobuhiro Sugano
    Kazuhito Tsuchida
    Soichiro Morinaga
    Makoto Akaike
    Yukio Sugimasa
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 365 - 370
  • [33] Phase II study of weekly irinotecan (CPT-11) associated to protracted oral tegafur (TGF) in previously untreated, advanced colorectal cancer (ACRC)
    Saigi, E
    Batiste-Alentorn, E
    Diaz, N
    Galan, A
    Salud, A
    Campos, JM
    Losa, F
    Gallen, M
    Massuti, B
    Asensio, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 302S - 302S
  • [34] Phase I study of irinotecan (CPT-11) combined with S-1 in patients with advanced gastric cancer(AGC)
    Komatsu, Y
    Takei, M
    Kato, T
    Miyagishima, T
    Kunieda, Y
    Tateyama, M
    Wakahama, O
    Takeda, H
    Kato, M
    Sugiyama, T
    Asaka, M
    Sakata, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 253 - 254
  • [35] A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer
    Shiozawa, Manabu
    Sugano, Nobuhiro
    Tsuchida, Kazuhito
    Morinaga, Soichiro
    Akaike, Makoto
    Sugimasa, Yukio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (03) : 365 - 370
  • [36] Phase I study of irinotecan (CPT-11) and capecitabine in combination with concurrent radiotherapy for locally advanced rectal cancer.
    Hofheinz, R
    Von Gerstenberg, B
    Wenz, F
    Gnad-Vogt, U
    Tiefenbacher, U
    Saussele, S
    Kreil, S
    Hochhaus, A
    Willeke, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 293S - 293S
  • [37] Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy
    Aravantinos, G
    Skarlos, DV
    Kosmidis, P
    Georgoulias, V
    Sgouros, I
    Bafaloukos, D
    Androulakis, N
    Florou, S
    Fountzilas, G
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 32 (03) : 209 - 219
  • [38] Irinotecan (CPT-11) metabolism and disposition in cancer patients
    Sparreboom, A
    de Jonge, MJA
    de Bruijn, P
    Brouwer, E
    Nooter, K
    Loos, WJ
    van Alphen, RJ
    Mathijssen, RHJ
    Stoter, G
    Verweij, J
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2747 - 2754
  • [39] A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)
    Laack, Eckart
    Thoem, Ina
    Kruell, Andreas
    Engel-Riedel, Walburga
    Mueller, Thomas
    Meissner, Christoph
    Duerk, Heinz
    Fischer, Juergen
    Guetz, Sylvia
    Kortsik, Cornelius
    Elbers, Matthias
    Schuch, Gunter
    Andritzkya, Birte
    Goern, Michael
    Burkholder, Iris
    Edler, Lutz
    Hossfeld, Dieter Kurt
    Bokemeyer, Carsten
    LUNG CANCER, 2007, 57 (02) : 181 - 186
  • [40] Phase II study of biweekly administration of CPT-11 and gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer in Japan.
    Takada, Ryoji
    Ioka, Tatsuya
    Ishida, Nobuko
    Yamai, Takuo
    Fukutake, Nobuyasu
    Ashida, Reiko
    Uehara, Hiroyuki
    Katayama, Kazuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345